Literature DB >> 32788856

GRACILIS MUSCLE TRANSFER TO ELBOW FLEXION IN BRACHIAL PLEXUS INJURIES.

Gustavo Bersani Silva1, Maurício Rodrigues Lima1, Alvaro Baik Cho1, Raquel Bernardelli Iamaguchi1, Marcelo Rosa de Resende1, Teng Hsiang Wei1.   

Abstract

OBJECTIVE: Brachial plexus injury can lead to significant functional deficit for the patient. Elbow flexion restoration is a priority in surgical treatment. Free functional muscle transfer is an option for early or late treatment failure. This study evaluated patient characteristics and elbow flexion muscle strength after gracilis functioning muscle transfer.
METHODS: Medical records of 95 patients operated from 2003 to 2019 were analyzed and the following variables recorded: age, gender, nerve transfer used to motorize the gracilis muscle, time between trauma and surgery, age at surgery and elbow flexion strength after a minimum of 12 months following functioning muscle transfer.
RESULTS: 87 patients were included, averaging 30 years of age (17 to 57 years). Fifty-five achieved elbow flexion muscle strength ≥ M3 (55/87, 65%), with a mean follow-up of 37 months. The nerves used for activation of the transferred gracilis were: 45 spinal accessory, 10 intercostal, 8 median n. fascicles, 22 ulnar n. fascicles and 2 phrenic nerves.
CONCLUSION: Functional muscle transfer is a viable surgical procedure for elbow flexion in chronic traumatic brachial plexus injuries in adults. Level of Evidence II, Retrospective study.

Entities:  

Keywords:  Brachial Plexus; Microsurgery; Surgical flaps

Year:  2020        PMID: 32788856      PMCID: PMC7405841          DOI: 10.1590/1413-785220202804233021

Source DB:  PubMed          Journal:  Acta Ortop Bras        ISSN: 1413-7852            Impact factor:   0.513


INTRODUCTION

Traumatic injury of the brachial plexus has gained special attention from the scientific community in recent decades, not only for being a devastating pathology, but also because its treatment imposes remarkable challenges on the professional involved. Notably, elbow flexion deficit represents a frequent problem for most patients with brachial plexus injury, with its reestablishment being the primary objective of treatment. ( Graft reconstructions and nerve transfers for elbow flexion are the preferred approach in early treated brachial plexus injuries. ( However, patients evaluated late (trauma-surgery interval above 12-18 months) show degeneration of the neuro-muscular junction of the upper limb muscles, an irreversible change that precludes reconstructions and nerve transfers to this musculature. ( When treatment is delayed or the surgical treatment fails in the acute phase - and there are no muscles strong enough for muscle transfer - the alternative to recover elbow flexion is free functional muscle transplant with intraplexual or extra-plexual nerve transfer, depending on the severity of the brachial plexus injury. ( )- ( Opting for free functional muscle transfer, a donor motor nerve for the transferred muscle must be selected. Total brachial plexus injuries commonly uses the accessory nerve and the intercostal nerves. For high partial injuries, in addition to these nerves, motor fascicles of the median nerve or ulnar nerve can also be transferred. ( Currently, the free gracilis flap is the most popular choice for elbow flexion reconstruction - a thin muscle with adequate strength and excursion, reliable neurovascular pedicle, easy dissection, resulting in little functional loss of the lower limb. ( This study aimed to describe the patients’ characteristics and the results of free gracilis muscle transfer to elbow flexion in chronic brachial plexus injuries in adults, after evaluating 87 consecutive cases performed at a university hospital.

MATERIALS AND METHODS

The study began after the formal authorization granted by the institution’s and Plataforma Brasil Research Ethics Committee under CAAE 52633015.0.0000.0068 and after all patients have signed the informed consent form. Between February 2003 and December 2019, 95 patients with traumatic brachial plexus injury underwent free transfer of the gracilis muscle to recover elbow flexion. The following variables were retrospectively collected by medical records analysis: age, gender, trauma mechanism, injury laterality, injury level, nerve transfer used to motorize the gracilis muscle, interval between trauma and surgical procedure, patient’s age during surgery, elbow flexion strength after a minimum of 12 months of free muscle transfer, relevant observations (complications, secondary surgeries, associated trauma, etc.). The inclusion criteria for the study were: patients older than 18 years of age who received a functioning gracilis muscle flap for elbow flexion reconstruction following post-traumatic brachial plexus injury. Patients with failed free gracilis flap or having less than 12 months of postoperative follow-up at the time of evaluation were excluded. Results after secondary surgery (e.g., Steindler and distal retensioning of the gracilis muscle insertion) were discarded. Patients subjected to secondary surgeries were included considering only the results after free transfer from gracilis muscle, that is, before additional surgeries. Two patients were excluded due to loss of the transferred free muscle (2/95; 2%), one after venous thrombosis of the flap and one due to infection. Six other patients were excluded due to total postoperative follow-up of less than 12 months, totaling 87 patients included in the study. Patients were divided into five groups according to the transferred nerve for activating the functional flap of the gracilis muscle: spinal accessory nerve (SAN), intercostal nerves (ICN), median nerve fascicle (MED), ulnar nerve fascicle (ULNAR) and phrenic nerve (PHR). The final elbow flexion muscle strength was assessed using the British Medical Research Council (BMRC) scale8 (Table 1). Considering that a patient undergoing a free functional flap has no normal muscle strength, the authors classified the research subjects from M0 to M4, deeming a good result M3 or more.
Table 1

British Medical Research Council (BMRC) Scale.8

Degree of muscle strength 
M0No muscle contraction
M1Muscle contraction not resulting in joint movement
M2Muscle contraction with movement excluding gravity
M3Muscle contraction effective against gravity but does not overcome resistance.
M4Muscle contraction that overcomes some resistance
M5Normal muscle strength

RESULTS

Of the 87 cases included in the analysis, 82 patients were male (94.2%) and 5 females (5.8%). The mean age was 30 years (ranging from 17 to 57 years). Of the 87 patients, 48 showed left laterality (55.1%) and 39 right laterality (44.9%). Regarding injury characteristics, 42 patients had partial injury (48.2%), 20 C5-6 injury (47%) and 22 C5-7 (53%), in addition to 45 presenting total injury (51.8%). Evaluating trauma mechanisms, we found 75 motorcycle accidents (86%), five hit-and-run (5%), two car accidents (3%), two bicycle accidents (3%) and two physical aggressions (3%). The mean interval between accident and surgery was 79 months (ranging from 8 to 1311 months). The mean follow-up time was 37 months (ranging from 13 to 154 months). Regarding functional strength, 55 cases had muscle strength ≥ M3 (65%): eight M0 (9%), nine M1 (10%), 15 M2 (17%), 30 M3 (35%) and 25 M4 (29%). The nerve transfers that activated free functional muscle flaps were: 45 spinal accessory nerve transfers (four using sural nerve graft and 41 cases without grafting), 10 intercostal nerves (three with graft and seven without), eight median nerve fascicles, 22 ulnar nerve fascicles and two phrenic nerves. Table 2 summarizes the results of the different donor nerve transfers to the functional muscle flap.
Table 2

Results per transferred nerve.

 OverallSANICNMEDULNARPHR
Good Result55/87 33/45 6/10 2/8 13/221/2
(≥ M3)(65%)(73.3%)(60.0%)(25.0%)(59.0%)(50%)
M08/873/453/10 0/81/22 1/2
(9%)(6.5%)(30.0%)(0.0%)(4.5%)(50.0%)
M19/87 4/45 0/102/83/22 
(10%)(9.0%)(0.0%)(25.0%)(13.6%) 
M215/87 5/45 1/10 4/8 5/22  
(17%)(11.0%)(10.0%)(50.0%)(22.8%) 
M330/87 22/45 3/10 1/8 3/221/2
(35%)(49.0%)(30.0%)(12.5%)(13.6%)(50.0%)
M425/87 11/453/101/8 10/22 
(29%)(24.5%)(30.0%)(12.5%)(45.5%) 

SAN: spinal accessory nerve; ICN: intercostal nerves; MED: median nerve. ULNAR: ulnar nerve; PHR: phrenic nerve.

SAN: spinal accessory nerve; ICN: intercostal nerves; MED: median nerve. ULNAR: ulnar nerve; PHR: phrenic nerve. The complications of the viable flaps were: four re-explorations - three for loss of the skin monitor with the viable flap and one compressed pedicle by hematoma - and four infections (two from the recipient site and one from the donor site), totaling 9.2%. The secondary surgeries were: eight proximal transfers of the flexo-pronator muscles (Steindler surgery) - five cases going from M2 to M4, two cases from M3 to M4, and one case that from M1 performed triceps to biceps transfer and after Steindler obtained final result of M4 - and one case of distal retensioning of the gracilis muscle insertion in the biceps tendon (without functional gain). Twelve patients who received free functional muscle transfer had previously undergone unsuccessful exploration and reconstruction of the brachial plexus (four graft reconstructions and eight nerve transfers).

DISCUSSION

This study reinforces the current understanding that traumatic brachial plexus injury primarily affects young men victimized in motorcycle accidents: 94.2% of the patients were male, with a mean age of 30 years. Flores ) and Anjos ) evaluated the victims of motorcycle accidents in different Brazilian states, concluding that they are basically young males. Brachial plexus injury represents a major impact on these victims’ lives due to the long treatment time and permanent functional deficit that it imposes on the injured. We believe that these demographic and natural history characteristics justify all efforts to try to restore the affected limb, even if partially. Based on Dyck et al., ( we used the British Medical Research Council (BMRC) scale to assess elbow flexion muscle strength. According to Bengtson et al., ( about three quarters of the publications that evaluate brachial plexus use this scale, being a simple and well-established method. An opinion shared by Bhardwaj et al., ( who state that this scale is the most popular to assess the return of elbow flexion, but alerting to the variances in inter-observer interpretation of the BMRC grading. Ikuta et al. ( ) were the first to describe free functioning muscle transfer connected to intercostal nerves for elbow flexion reconstruction, with their initial report being followed by numerous publications that selected different nerve donor sources. ( ), ( Chung et al. ( reported free gracilis muscle transfer to elbow flexion using intercostal nerves as the donor, with 78% of patients reaching flexion strength M4 or higher; Krakauer et al. ( reported M3 or more in three of their four patients (75%) while Chuang et al., ( studied 16 cases and 81.2% achieved M3 or more elbow flexion strength. Success rate (≥ M3) of the present study (60%, 6/10) after intercostal nerve transfer to the transplanted gracilis was slightly lower than previously reported. Barrie et al. ( reviewed 26 patients who underwent free transfer of the gracilis muscle, with intercostal nerves or spinal accessory nerve as the donors, and reported functional elbow flexion in 63% of cases. Kay et al. ( studied 33 functioning transfers of the gracilis muscle, most of which were attached to intercostal nerves (15 cases) or ulnar nerve fascicles (12 cases) with an overall success rate (≥ M3) of 70%; when only adults were included, this rate reached 53%. Intercostal nerves group yielded better results regarding elbow flexion strength. In the present study the overall good results (≥ M3) reached 65% while ulnar nerve fascicles transfer group achieved a success rate of 59%, similar to the intercostal nerves group (60%). Sungpet et al. ( assessed the result of free gracilis transfer to elbow flexion in three patients with high brachial plexus injury (C5/C6), using an ulnar nerve fascicle as donor nerve. After a 33-month follow-up, an average elbow flexion muscle strength of 4.3 kg was observed. The authors reported no loss of hand grip strength or wrist flexion, as well as no change in sensitivity. The advantages of using the ulnar nerve as a donor are highlighted, being easy to perform, avoiding the use of nerve grafts and enabling voluntary control of elbow flexion. The authors of the present study report similar outcomes as ulnar nerve transfer proved to be a reliable procedure, with satisfactory results and no sensory-motor deficit of the donor nerve. Limitations of this study were its retrospective nature and the qualitative assessment of elbow flexion strength (even though the BMRC scale is vastly used in the literature). Likewise, the limited number of patients operated on in some groups (median, intercostal, and phrenic) hinder in-depth group comparison. Data from handwritten medical records was eventually challenging to interpret. The patients’ individual effort during assessment and rehabilitation may impact the results. Limitations of this study were its retrospective nature and the qualitative assessment of elbow flexion strength (even though the BMRC scale is vastly used in the literature). Likewise, the limited number of patients operated on in some groups (median, intercostal, and phrenic) hinder in-depth group comparison. Data from handwritten medical records was eventually challenging to interpret. The patients’ individual effort during assessment and rehabilitation may impact the results.

CONCLUSION

The free functioning transfer of the gracilis muscle for traumatic brachial plexus injuries is a reliable surgical technique for gaining elbow flexion in adults. Further studies are needed to elucidate the role of accessory, intercostal, median, ulnar, and phrenic nerves in activating functional muscle flaps for upper limb reconstruction.
  18 in total

Review 1.  Functioning free-muscle transfer for brachial plexus injury.

Authors:  Allen T Bishop
Journal:  Hand Clin       Date:  2005-02       Impact factor: 1.907

2.  Inverted free functional gracilis muscle transfer for the restoration of elbow flexion.

Authors:  K Chin; D Vasdeki; A Hart
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-10-13       Impact factor: 2.740

3.  The principles of functioning muscle transplantation: applications to the upper arm.

Authors:  R T Manktelow; R M Zuker
Journal:  Ann Plast Surg       Date:  1989-04       Impact factor: 1.539

4.  Free muscle graft as applied to brachial plexus injury-case report and experimental study.

Authors:  Y Ikuta; K Yoshioka; K Tsuge
Journal:  Ann Acad Med Singap       Date:  1979-10       Impact factor: 2.473

5.  Free Gracilis muscle transfer to restore elbow flexion in brachial plexus injuries.

Authors:  B Coulet; C Boch; J Boretto; C Lazerges; M Chammas
Journal:  Orthop Traumatol Surg Res       Date:  2011-11-22       Impact factor: 2.256

6.  The treatment of brachial plexus injuries.

Authors:  A O Narakas
Journal:  Int Orthop       Date:  1985       Impact factor: 3.075

7.  Transfer of one fascicle of ulnar nerve to functioning free gracilis muscle transplantation for elbow flexion.

Authors:  Adisak Sungpet; Chanyut Suphachatwong; Viroj Kawinwonggowit
Journal:  ANZ J Surg       Date:  2003-03       Impact factor: 1.872

8.  Functional restoration of elbow flexion in brachial plexus injuries: results in 167 patients (excluding obstetric brachial plexus injury).

Authors:  D C Chuang; M D Epstein; M C Yeh; F C Wei
Journal:  J Hand Surg Am       Date:  1993-03       Impact factor: 2.230

Review 9.  Gracilis free muscle transfer for restoration of function after complete brachial plexus avulsion.

Authors:  Kimberly A Barrie; Scott P Steinmann; Alexander Y Shin; Robert J Spinner; Allen T Bishop
Journal:  Neurosurg Focus       Date:  2004-05-15       Impact factor: 4.047

10.  MICROSURGICAL TRANSFER OF THE GRACILIS MUSCLE FOR ELBOW FLEXION IN BRACHIAL PLEXUS INJURY IN ADULTS: RETROSPECTIVE STUDY OF EIGHT CASES.

Authors:  Luiz Koiti Kimura; Alexandre Tadeu do Nascimento; Roberto Capócio; Rames Mattar; Marcelo Rosa Rezende; Teng Hsiang Wei; Luciano Ruiz Torres; Fernando Munhoz Moya
Journal:  Rev Bras Ortop       Date:  2015-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.